CAS No.525-66-6,1-Isopropylamino-3-(naphthalen-1-yloxy)-propan-2-ol Suppliers

Products Categories

Pharmaceutical (36)
Others (10)
Organic Chemicals (2)

Basic Information

Molecular Structure:
CAS No.:	525-66-6
Name:	1-Isopropylamino-3-(naphthalen-1-yloxy)-propan-2-ol
Article Data:	126

Formula:	C16H21 N O2
Molecular Weight:	259.348
Synonyms:	2-Propanol,1-(isopropylamino)-3-(1-naphthyloxy)- (7CI,8CI); (?à)-Propranolol; 1-(1-Naphthyloxy)-3-(isopropylamino)-2-propanol;1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol;3-(Naphth-1-yloxy)-1-(isopropylamino)propan-2-ol; AY 64043; Betalong;DL-Propranolol; Euprovasin; Innopran XL; Propranolol; Proprasylyt; Racemicpropranolol; Reducor; dl-Propranolol; b-Propranolol
EINECS:	208-378-0
Density:	1.093 g/cm³
Melting Point:	163-164 °C
Boiling Point:	434.9 °C at 760 mmHg
Flash Point:	216.8 °C
Solubility:	Sol of 1 in 20 of water or alcohol; sltly sol in chloroform; practically insol in ether.
Appearance:	White, odorless crystalline powder.
Hazard Symbols:	Highly toxic.
Safety:	A deadly human poison by ingestion and intravenous routes. Poison experimentally by ingestion, intraperitoneal, intravenous, and subcutaneous routes. Human systemic effects by ingestion: cardiac arrhythmias, hallucinations, hypoglycemia, convulsions, and thyroid malfunction. Human reproductive and teratogenic effects by ingestion: extra embryonic structures, abnormal Apgar score in newborn, and abnormal growth statistics. Mutation data reported. When heated to decomposition it emits toxic fumes of NO_x. See also INDERAL HYDROCHLORIDE.
PSA:	41.49000
LogP:	2.96840

Synthetic route

: 91740-63-5
3-isopropyl-5-<(nphthyloxy)methyl>oxazolidin-2-one

: 525-66-6
propranolol

Conditions

Conditions	Yield
With potassium hydroxide In benzene for 24h; Heating;	100%

: 2461-42-9
3-(1-naphthyloxy)-1,2-epoxypropane

: 75-31-0
isopropylamine

: 525-66-6
propranolol

Conditions

Conditions	Yield
With acetic acid In water at 20℃; for 8h;	99%
In water	94%
Stage #1: 3-(1-naphthyloxy)-1,2-epoxypropane With calcium chloride In acetonitrile Stage #2: isopropylamine In acetonitrile Further stages.;	93%

: 2461-42-9
3-(1-naphthyloxy)-1,2-epoxypropane

: 79-46-9
2-nitropropane

: 525-66-6
propranolol

Conditions

Conditions	Yield
With sodium tetrahydroborate; nickel(II) chloride hexahydrate In water at 20℃; for 24h; Inert atmosphere; Green chemistry;	94%

: 90-15-3
α-naphthol

: 75-31-0
isopropylamine

: 106-89-8
epichlorohydrin

: 525-66-6
propranolol

Conditions

Conditions	Yield
With tetrabutylammomium bromide; sodium hydroxide In water at 0 - 100℃; for 5h; Reagent/catalyst; Solvent;	90%
Stage #1: α-naphthol; epichlorohydrin With potassium tert-butylate In dimethyl sulfoxide at 70℃; for 0.333333h; Williamson Ether Synthesis; Flow reactor; Stage #2: isopropylamine In dimethyl sulfoxide at 140℃; under 5250.53 Torr; for 0.333333h; Flow reactor;	47 %Chromat.

...Expand

: 2007-16-1
(RS)-1-bromo-3-(1-naphthyloxy)-2-propanol

: 75-31-0
isopropylamine

: 525-66-6
propranolol

Conditions

Conditions	Yield
In 5,5-dimethyl-1,3-cyclohexadiene at 40℃; for 4h; Solvent; Temperature;	88.9%

: 2461-42-9
3-(1-naphthyloxy)-1,2-epoxypropane

: 75-31-0
isopropylamine

A: 83314-78-7
N-Isopropyl-N,N-di-<3-(1-naphthoxy)-2-hydroxypropyl>amin

B: 525-66-6
propranolol

Conditions

Conditions	Yield
In toluene for 4h;	A 60% B n/a

...Expand

: 82616-68-0
1-(3,4-Dihydro-naphthalen-1-yloxy)-3-isopropylamino-propan-2-ol

: 525-66-6
propranolol

Conditions

Conditions	Yield
With 2,3-dicyano-5,6-dichloro-p-benzoquinone	59%

: 75-31-0
isopropylamine

: 2,2-Dichloro-3-(naphthalen-1-yloxymethyl)-oxirane

A: C24H20O2

B: C24H20O2

C: 525-66-6
propranolol

Conditions

Conditions	Yield
In tetrahydrofuran	A n/a B n/a C 35%

...Expand

: 20133-93-1
1-chloro-3-(1-naphthoxy)-2-propanol

: 75-31-0
isopropylamine

: 525-66-6
propranolol

: 129459-75-2
1-(isopropylamino)-3-(naphthalen-1-yloxy)propan-2-yl acetate

: 525-66-6
propranolol

Conditions

Conditions	Yield
at 37℃; Rate constant; plasma intestine and liver of rats;

Raw Materials

318-98-9

106-89-8

711-82-0

90-15-3

75-31-0

Downstream Products

Total:45 Page 1 of 2 1 2 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 525-66-6

Chemistry

Molecular Structure of Inderal (CAS NO.525-66-6):

Molecular Formula: C₁₆H₂₁NO₂
Molecular Weight: 259.34344
IUPAC Name: 1-(Isopropylamino)-3-(1-naphthyloxy)propan-2-ol
CAS: 525-66-6
EINECS: 208-378-0
SMILES: OC(CNC(C)C)COc2cccc1ccccc12
InChI: InChI=1/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3
InChIKey: AQHHHDLHHXJYJD-UHFFFAOYAS
Std.InChI: InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3
Std.InChIKey: AQHHHDLHHXJYJD-UHFFFAOYSA-N
Melting Point: 163-164℃
Boiling Point: 434.9℃ at 760mmHg
Flash Point: 216.8℃
Molar Volume: 237.1cm³
Density: 1.093g/cm³
Index of Refraction: 1.58
Molar Refractivity: 78.98cm³
Surface Tension: 42.6dyne/cm
Polarizability: 31.31 10^-24cm³
Enthalpy of Vaporization: 72.84kJ/mol
Vapour Pressure: 2.48E-08mmHg at 25℃

Uses

Inderal (CAS NO.525-66-6) can be used for medication (vet).

Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
child	LDLo	oral	800ug/kg/12H (0.8mg/kg)	CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA	British Medical Journal. Vol. 2, Pg. 254, 1978.
child	TDLo	oral	400mg/kg (400mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)	Medical Journal of Australia. Vol. 1, Pg. 82, 1981.
dog	LDLo	intraperitoneal	40mg/kg (40mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Pharmazie. Vol. 31, Pg. 635, 1976.
dog	LDLo	oral	120mg/kg (120mg/kg)	SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE BEHAVIORAL: ATAXIA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 69(4), Pg. 262P, 1973.
guinea pig	LD50	intravenous	26mg/kg (26mg/kg)		Dissertationes Pharmaceuticae et Pharmacologicae. Vol. 24, Pg. 103, 1972.
human	LDLo	intravenous	71ug/kg (0.071mg/kg)		Lancet. Vol. 1, Pg. 165, 1967.
human	TDLo	oral	2300ug/kg/D (2.3mg/kg)	BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"	British Medical Journal. Vol. 1, Pg. 1182, 1978.
man	TDLo	oral	8343mg/kg/4Y- (8343mg/kg)	ENDOCRINE: EVIDENCE OF THYROID HYPERFUNCTION	Archives of Internal Medicine. Vol. 143, Pg. 2193, 1983.
man	TDLo	unreported	22857ug/kg/40 (22.857mg/kg)	SENSE ORGANS AND SPECIAL SENSES: CHANGE IN ACUITY: EAR	British Medical Journal. Vol. 289, Pg. 1490, 1984.
mouse	LD50	intraperitoneal	42mg/kg (42mg/kg)	AUTONOMIC NERVOUS SYSTEM: BETA ADRENERGIC BLOCKAGE	Ain Shams Medical Journal. Vol. 30, Pg. 23, 1979.
mouse	LD50	intravenous	24400ug/kg (24.4mg/kg)		United States Patent Document. Vol. #4013663,
mouse	LD50	oral	289mg/kg (289mg/kg)	AUTONOMIC NERVOUS SYSTEM: BETA ADRENERGIC BLOCKAGE	Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 1831, 1980.
mouse	LD50	subcutaneous	150mg/kg (150mg/kg)		Farmakologiya i Toksikologiya Vol. 44, Pg. 342, 1981.
rat	LD50	intravenous	23mg/kg (23mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA	Pharmazie. Vol. 31, Pg. 635, 1976.
rat	LD50	oral	660mg/kg (660mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA	Pharmazie. Vol. 31, Pg. 635, 1976.
women	LDLo	oral	120mg/kg (120mg/kg)		Acta Pharmacologica et Toxicologica. Vol. 41, Pg. 190, 1977.
women	TDLo	oral	3200ug/kg/2D- (3.2mg/kg)	ENDOCRINE: HYPOGLYCEMIA	Israel Journal of Medical Sciences. Vol. 18, Pg. 725, 1982.
women	TDLo	oral	708mg/kg/39W- (708mg/kg)		Annals of Pharmacotherpy. Vol. 27, Pg. 512, 1993.

Safety Profile

A deadly human poison by ingestion and intravenous routes. Poison experimentally by ingestion, intraperitoneal, intravenous, and subcutaneous routes. Human systemic effects by ingestion: cardiac arrhythmias, hallucinations, hypoglycemia, convulsions, and thyroid malfunction. Human reproductive and teratogenic effects by ingestion: extra embryonic structures, abnormal Apgar score in newborn, and abnormal growth statistics. Mutation data reported.

Specification

Inderal (CAS NO.525-66-6),which also can be called for 1-Isopropylamino-3-(1-naphthyloxy)propan-2-ol ; Propranolol Base ; 1-[Isopropylamino]-3-[1-naphthyloxy]-2-propanol ; 2-Propanol,1-(1-methylethyl)amino-3-(1-naphthalenyloxy)- ; 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol ; 1-(1-Naphthyloxy)-3-(isopropylamino)-2-propanol ; 2-Propanol,1-(isopropylamino)-3-(1-naphthyloxy)- (7CI,8CI) ; 2-Propanol,1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)- (9CI) .When Inderal (525-66-6) was heated,it emits toxic fumes of NOx .This chemical is a crystals from Cyclohexane and it's slightly soluble in water.It is stable to heat, unstable to light.